Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

Cogent Biosciences (COGT) Asset Utilization Ratio (2018 - 2021)

Cogent Biosciences has reported Asset Utilization Ratio over the past 4 years, most recently at 0.0 for Q2 2021.

  • Quarterly results put Asset Utilization Ratio at 0.0 for Q2 2021, down 99.8% from a year ago — trailing twelve months through Jun 2021 was 0.0 (down 99.8% YoY), and the annual figure for FY2020 was 0.05, down 84.23%.
  • Asset Utilization Ratio for Q2 2021 was 0.0 at Cogent Biosciences, down from 0.0 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for COGT hit a ceiling of 0.68 in Q2 2020 and a floor of 0.0 in Q2 2021.
  • Median Asset Utilization Ratio over the past 4 years was 0.14 (2019), compared with a mean of 0.21.
  • Biggest five-year swings in Asset Utilization Ratio: surged 374.14% in 2020 and later crashed 99.8% in 2021.
  • Cogent Biosciences' Asset Utilization Ratio stood at 0.11 in 2018, then soared by 289.25% to 0.42 in 2019, then plummeted by 90.39% to 0.04 in 2020, then plummeted by 96.68% to 0.0 in 2021.
  • The last three reported values for Asset Utilization Ratio were 0.0 (Q2 2021), 0.0 (Q1 2021), and 0.04 (Q4 2020) per Business Quant data.